The point related to this stk whether its a bag of #$%$ or not is the fact that this news is real.. Orphan status is pretty significant. I have seen stks double and triple based on this sort of news and much less senseless news.
It's all about the merger and next qtr. This report will get a pass at first.
10 billion are you serious? I's going to be more like 50 billion. Not all at once but highly unlikely gross does not have personal ties to customers there that would follow him to Jebrew if he went. and my figure takes into account 5 % and that's peanuts.
Yes your post makes so much sense. first of all the co' does not want to be bought out. An offer will come out of the blue. If data is 100 % effective stk jumps to 18/19. Then the negotiations will come. Even if they take 10 % mkt share they can do well on their own,, but that won't happen either, I think big pharma pays 2.5 billion for this one if n only if the study gets to phase 3. I am long btw w/ puts at 10. I wish they would release the data now but am thinking end of November. Must allow time after the 13 wk trial to see if control study stays free of HSv
$4 pvt placement. Thank you. You were right as dumb as it sounds someties the info u get on here is spot on. My firm laughed at me. Ca ching.
Am out covered 4.47
Please let me know some facts, if you're just making this stuff up you're crazy. If you can drop a few names here and there about where you heard this I will confirm it and post it on Twitter. I have a decent following. But if what you're saying is not true you can be penalized from the sec. And believe me they will crack down,, Actually I am an idiot for paying any attention to this. I can ask the SEC through the web site.
This stk should run up into aapl's conf I think. It's been out there that aapl may introduce a 3d phone.